PEOPLE CURED SINCE 2009
PROGRAMS IN 11 COUNTRIES
A NEW HUMANITARIAN APPROACH
“Millions of children die every year from preventable diseases. This is what motivates us to treat and care for as many people as we can,” Dr Susan Shepherd, pediatrician, ALIMA
ALIMA pools the expertise of international aid workers, national medical organizations and global research institutions to provide quality medical care to people in need and carry out cutting-edge research to improve humanitarian medicine.
By sharing resources and know-how, ALIMA and its partners are increasing access to care for communities at risk and expanding humanitarian medical response capacity in some of the most challenging contexts in the world.
Since its creation in 2009, ALIMA has treated more than 2 million patients, conducted 41 programs in 12 countries and launched ten research projects focusing on malnutrition, malaria, Ebola, and surgery. ALIMA has teams dedicated to acute emergencies and recurring crises.
Innovation and Research
Infectious diseases cause 60% of all childhood deaths in Africa, yet they are the subject of only 2% of medical research trials worldwide. Even less research is devoted to improving emergency humanitarian medicine.
ALIMA invests in operational and clinical research to improve medical care in humanitarian emergencies, including trauma surgery, nutrition, paediatric care, and Ebola prevention and treatment.
A unique alliance
ALIMA works hand-in-hand with a network of local and national medical organizations to provide life-saving care to some of the world’s most neglected communities. By sharing skills, resources and local knowledge, ALIMA gains a deeper understanding of the contexts where we work. This helps improve the acceptance and impact of our programmes. ALIMA’s medical research priorities are determined by the network and benefit further from partnerships with international organizations and academic research institutions. Leaders of ALIMA’s network of local and national medical organizations are also members of ALIMA’s international board of directors.